chrX-74739447-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001008537.3(NEXMIF):āc.4509T>Cā(p.Pro1503=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00105 in 1,198,042 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 372 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00052 ( 0 hom., 10 hem., cov: 21)
Exomes š: 0.0011 ( 0 hom. 362 hem. )
Consequence
NEXMIF
NM_001008537.3 synonymous
NM_001008537.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 6.42
Genes affected
NEXMIF (HGNC:29433): (neurite extension and migration factor) An inversion on the X chromosome which disrupts this gene and a G-protein coupled purinergic receptor gene located in the pseudoautosomal region of the X chromosome has been linked to X linked cognitive disability.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant X-74739447-A-G is Benign according to our data. Variant chrX-74739447-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 211270.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 10 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NEXMIF | NM_001008537.3 | c.4509T>C | p.Pro1503= | synonymous_variant | 4/4 | ENST00000055682.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NEXMIF | ENST00000055682.12 | c.4509T>C | p.Pro1503= | synonymous_variant | 4/4 | 1 | NM_001008537.3 | P1 | |
NEXMIF | ENST00000616200.2 | c.4509T>C | p.Pro1503= | synonymous_variant | 4/5 | 1 | P1 | ||
NEXMIF | ENST00000642681.2 | c.*649T>C | 3_prime_UTR_variant | 3/3 |
Frequencies
GnomAD3 genomes AF: 0.000516 AC: 57AN: 110384Hom.: 0 Cov.: 21 AF XY: 0.000307 AC XY: 10AN XY: 32590
GnomAD3 genomes
AF:
AC:
57
AN:
110384
Hom.:
Cov.:
21
AF XY:
AC XY:
10
AN XY:
32590
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000614 AC: 102AN: 166139Hom.: 0 AF XY: 0.000681 AC XY: 37AN XY: 54297
GnomAD3 exomes
AF:
AC:
102
AN:
166139
Hom.:
AF XY:
AC XY:
37
AN XY:
54297
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1200AN: 1087605Hom.: 0 Cov.: 27 AF XY: 0.00102 AC XY: 362AN XY: 354997
GnomAD4 exome
AF:
AC:
1200
AN:
1087605
Hom.:
Cov.:
27
AF XY:
AC XY:
362
AN XY:
354997
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000516 AC: 57AN: 110437Hom.: 0 Cov.: 21 AF XY: 0.000306 AC XY: 10AN XY: 32653
GnomAD4 genome
AF:
AC:
57
AN:
110437
Hom.:
Cov.:
21
AF XY:
AC XY:
10
AN XY:
32653
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 25, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | NEXMIF: BP4, BS2 - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 17, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
NEXMIF-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 10, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at